Small doses of insulin may prevent the decrease of intrinsic insulin secretion in anti-GAD, ICA and IA-2 antibody-positive slowly progressive type 1 diabetes

Journal of the Japan Diabetes Society

Volumn 48, Issue 4, 2005, Pages 257-261

  Matsumoto, M ^a   Satou, S ^a  

^a NONE

Author keywords

GAD; IA 2; ICA

Indexed keywords

ANTIBODY; GLUCAGON; GLUCOSE; GLUTAMATE DECARBOXYLASE ANTIBODY; INSULIN;

ADULT; ARTICLE; BLOOD SAMPLING; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RELEASE; LOADING TEST; LOW DRUG DOSE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SYMPTOM;

EID: 20444366593     PISSN: 0021437X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Kobayashi T, Tamemoto K, Nakanishi K, Kato N, Okubo M, Kajio H, Sugimoto T, Murase T, Kosaka K (1993) Immunogenetic and clinical characterization of slowly progressive IDDM. Diabetes Care 16: 780-788
2. Kasuga A, Maruyama T, Nakamoto S, Ozawa Y, Suzuki Y, Saruta T ( 1999) High-titer autoantibodies against glutamic acid decarboxylase plus autoantibodies against insulin and IA-2 predicts insulin requirement in adult diabetic patients. J Autoimmun 12: 131-135
3. Takino H, Yamasaki H, Abiru N, Sera Y, Abe T, Kawasaki E, Yamaguchi Y, Eguchi K, Kanazawa Y, Nagataki S (2002) Antibodies to GAD in Japanese patients classified as Type 2 diabetes at diagnosis. High titre of GAD Ab is predictive marker for early insulin treatment-report of west Japan (Kyushu, Yamaguchi, Osaka) study for GAD Ab (+) diabetes. Diabet Med 19: 730-734
4. Kobayashi T, Nakanishi K, Okubo M, Murase T, Kosaka K (1996) GAD antibodies seldom disappear in slowly progressive IDDM. Diabetes Care 19: 1031
5. Abiru N, Takino H, Yano M, Kawasaki E, Yamasaki H, Yamaguchi Y, Akazawa S, Nagataki S (1996) Clinical evaluation of non-insulin-dependent diabetes mellitus patients with autoantibodies to glutamic acid decarboxylase. J Autoimmun 9: 683-688
6. Kasuga A, Ozawa Y, Maruyama T, Ishihara T, Amemiya S, Saruta T (1997) Autoantibody against IA-2 improve the test sensitivity for insulin-dependent diabetes mellitus in Japanese patients of child onset. Endocr J 44: 485-491
7. Kobayashi T, Nakanishi K, Murase T, Kosaka K (1996) Small doses of subcutaneous insulin as a strategy for preventing slowly progressive β-cell failure in islet cell antibody-positive patients with clinical features of NIDDM. Diabetes 45: 622-626